Medicare Pressure Returns

Even with the FY26 guidance raise, investors remain sensitive to Medicare Advantage utilization and the finalized 2.48% 2027 payment increase. If cost growth outpaces reimbursement, the Q3 beat could be viewed as a temporary pause in a longer margin squeeze.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.